HealthEquity, Inc. logo HQY - HealthEquity, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 24
HOLD 1
SELL 1
STRONG
SELL
0
| PRICE TARGET: $109.89 DETAILS
HIGH: $125.00
LOW: $89.00
MEDIAN: $110.00
CONSENSUS: $109.89
UPSIDE: 24.72%

Stock News

The Triple Tax Free HSA Account High Earners Are Funding Before Maxing Their 401(k)

The Triple Tax Free HSA Account High Earners Are Funding Before Maxing Their 401(k)

Picture a dual-income couple with combined wages well into the high six figures. They already max the 401(k). Their employer offers a high-deductible health plan, and they keep choosing the lower-premium PPO out of habit. That habit is costing them the most tax-advantaged account in the entire IRS code. The HSA is the only vehicle... The Triple Tax Free HSA Account High Earners Are Funding Before Maxing Their 401(k)

May 22, 2026 05:47 PM 247wallst.com
HealthEquity: Compounding Flywheel Reveals Attractive Entry Point

HealthEquity: Compounding Flywheel Reveals Attractive Entry Point

HealthEquity is a leading HSA administrator, benefiting from rising healthcare costs and recent legislative tailwinds expanding its addressable market. Revenue grew 9% in FY2026 to $1.313 billion, with significant margin expansion and a standout 17% growth in custodial revenue driven by enhanced rate migration. Management projects further yield increases in FY2027, and a major low-yield contract expiry is set to boost custodial revenue meaningfully.

May 22, 2026 09:32 AM seekingalpha.com
HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its first quarter of fiscal 2027, after the close of regular stock market trading on Thursday, May 28, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, May 28, 2026, at 4:30 p.m.

May 05, 2026 12:01 PM globenewswire.com
Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF)

Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF)

HealthEquity (NASDAQ: HQY - Get Free Report) and bioMerieux (OTCMKTS:BMXMF - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Institutional and Insider Ownership 99.6% of HealthEquity shares are held

Apr 20, 2026 11:21 PM defenseworld.net
HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

HealthEquity is upgraded from 'Hold' to 'Buy,' reflecting visible operating leverage and durable growth drivers. HQY's fiscal Q4 2026 saw 7% revenue growth, 500+ bps margin expansion, and 23% adjusted EBITDA growth, signaling an earnings inflection. Structural tailwinds include expanded HSA eligibility, rising engagement, and a shift toward higher-value, compounding accounts.

Apr 16, 2026 04:10 AM seekingalpha.com
Head-To-Head Analysis: XWELL (NASDAQ:XWEL) versus HealthEquity (NASDAQ:HQY)

Head-To-Head Analysis: XWELL (NASDAQ:XWEL) versus HealthEquity (NASDAQ:HQY)

XWELL (NASDAQ: XWEL - Get Free Report) and HealthEquity (NASDAQ: HQY - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends. Analyst Recommendations This is a summary of current ratings and

Apr 12, 2026 09:58 PM defenseworld.net
Capricorn Fund Managers Ltd Takes $6.93 Million Position in HealthEquity, Inc. $HQY

Capricorn Fund Managers Ltd Takes $6.93 Million Position in HealthEquity, Inc. $HQY

Capricorn Fund Managers Ltd purchased a new position in HealthEquity, Inc. (NASDAQ: HQY) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 75,602 shares of the company's stock, valued at approximately $6,926,000. HealthEquity accounts for 1.7% of Capricorn Fund Managers Ltd's

Apr 06, 2026 12:43 AM defenseworld.net

Price Targets